Drawing for TOGETHER WE CURE

USPTO serial 85624863

TOGETHER WE CURE

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
TURNER, JASON FITZGERALD
Law office
TTAB

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 604: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with TOGETHER WE CURE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Amanda J. Carmany-Rampey, Ph.D.

AMANDA J CARMANY-RAMPEY KNOBBE MARTENS OLSON & BEAR LLP2040 MAIN ST FL 14IRVINE, CA 92614-8214UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Providing referrals in the field of leukemia support for patients and families of patients with leukemiaABANDONED—
042Creating an online community for individuals diagnosed with leukemia and their families for the purpose of collecting information and obtaining authorization and consent for the use collected information and clinical samples in scientific research and analysis; Creating an online community for clinical researchers and individuals diagnosed with leukemia for the purpose of sharing information and identifying individuals for participation in clinical trials; Providing genetic testing services and information in the field of leukemia research; Genomic and RNA analysis services for research and analysis in the fields of genetic profiling and leukemia diagnosis, disease classification and treatment; Compiling data for research purposes in the field of medical genetic testing and leukemia diagnosis, disease classification and treatment; Providing information on the subject of scientific research in the field of leukemia diagnosis, disease classification and treatment; Providing a website featuring technology enabling physicians and clinical researchers to access and exchange information and resources in clinical medicine regardless of medical organization or geographic location; and DNA screening for scientific research purposesABANDONED—
044Internet-based health care information services; Providing a website featuring information in the field of the diagnosis and treatment of leukemia; Providing information in the field of screening, diagnosis and treatment of leukemia; Providing an online computer database featuring medical information regarding genetic profile and leukemia classification; Health care services, namely, providing a database in the field of leukemia and genetic testing information and featuring inputting and collection of data and information all for treatment and diagnostic purposes; Internet-based medical diagnosis pertaining to leukemia, namely, providing information regarding genetic profile and leukemia and possible treatments and likely outcomes; Providing medical diagnostic testing and reporting services; DNA screening for medical purposes; and Providing genetic testing and consultation services for the diagnosis, monitoring and treatment of leukemiaABANDONED—
045Providing personal support services for patients and families of patients with leukemia, namely, emotional counseling, informational support, and social networking in the field of leukemia support provided via a websiteABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 9, 2013MAB4ABANDONMENT NOTICE MAILED - INTER PARTES DECISION—
Sep 9, 2013ABN4ABANDONMENT - AFTER INTER PARTES DECISION—
Sep 9, 2013OP.TOPPOSITION TERMINATED NO. 999999—
Sep 9, 2013OP.SOPPOSITION SUSTAINED NO. 999999—
May 29, 2013OP.IOPPOSITION INSTITUTED NO. 999999—
May 29, 2013OPPFOPPOSITION PAPERS RECEIVED AT TTAB—
Apr 30, 2013NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 30, 2013PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 10, 2013NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 22, 2013PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 21, 2013ALIEASSIGNED TO LIE—
Mar 8, 2013CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 8, 2013TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 7, 2013CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 7, 2013TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 10, 2012GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 10, 2012GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 10, 2012CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 5, 2012DOCKASSIGNED TO EXAMINER—
May 18, 2012NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 17, 2012NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance